MX2011009746A - Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. - Google Patents
Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica.Info
- Publication number
- MX2011009746A MX2011009746A MX2011009746A MX2011009746A MX2011009746A MX 2011009746 A MX2011009746 A MX 2011009746A MX 2011009746 A MX2011009746 A MX 2011009746A MX 2011009746 A MX2011009746 A MX 2011009746A MX 2011009746 A MX2011009746 A MX 2011009746A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- groups
- alkoxy
- cycloalkyl
- therapeutic use
- Prior art date
Links
- -1 6-aza-bicyclo[3.2.1]oct-5-yl Chemical group 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a un compuesto de fórmula general (I) en donde: R es un átomo de hidrógeno o un grupo elegido de los grupos alquilo de 1 a 6 átomos de carbono o cicloalquilo de 3 a 7 átomos de carbono opcionalmente sustituido con uno o más grupos elegidos independientemente de un átomo de halógeno, y los grupos cicloalquilo de 3 a 7 átomos de carbono, alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono e hidroxi; R1 es un grupo fenilo opcionalmente sustituido con uno o más sustituyentes elegidos independientemente de átomos de halógeno y los grupos alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono, halo-alquilo de 1 a 6 átomos de carbono, hidroxi, halo-alcoxi de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono-tio, alquilo de 1 a 6 átomos de carbono-SO, alquilo de 1 a 6 átomos de carbono-SO2 R2 es uno o más sustituyentes elegidos de un átomo de hidrógeno, átomos de halógeno y los grupos halo-alquilo de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono, cicloalquilo de 3 a 7 átomos de carbono, cicloalquilo de 3 a 7 átomos de carbono-alquilo de 1 a 3 átomos de carbono, fenilo, bencilo, alcoxi de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono-tio, alquilo de 1 a 6 átomos de carbono-SO, y alquilo de 1 a 6 átomos de carbonoSO2; y Het es un grupo heteroarilo; en donde el compuesto está en la forma de una base o una sal de adición a un ácido. La invención también se refiere al uso terapéutico de la misma y a un método para síntesis de la misma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901220A FR2943059A1 (fr) | 2009-03-16 | 2009-03-16 | Derives de n-°6-aza-bicyclo°3.2.1!oct-5-yl)-aryl-methyl!- heterobenzamide,leur preparation et leur application en therapeutique |
| PCT/FR2010/050448 WO2010106270A1 (fr) | 2009-03-16 | 2010-03-15 | Derives de n-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011009746A true MX2011009746A (es) | 2011-09-29 |
Family
ID=40720092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011009746A MX2011009746A (es) | 2009-03-16 | 2010-03-15 | Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20120029027A1 (es) |
| EP (1) | EP2408778A1 (es) |
| JP (1) | JP2012520346A (es) |
| KR (1) | KR20120013325A (es) |
| CN (1) | CN102356084A (es) |
| AR (1) | AR075838A1 (es) |
| AU (1) | AU2010224721A1 (es) |
| BR (1) | BRPI1009497A2 (es) |
| CA (1) | CA2755528A1 (es) |
| FR (1) | FR2943059A1 (es) |
| IL (1) | IL215103A0 (es) |
| MX (1) | MX2011009746A (es) |
| RU (1) | RU2011141760A (es) |
| SG (1) | SG174432A1 (es) |
| TW (1) | TW201100431A (es) |
| UY (1) | UY32496A (es) |
| WO (1) | WO2010106270A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
| KR102269305B1 (ko) | 2016-06-13 | 2021-06-25 | 길리애드 사이언시즈, 인코포레이티드 | Fxr (nr1h4) 조정 화합물 |
| CA2968836A1 (en) | 2016-06-13 | 2017-12-13 | Gilead Sciences, Inc. | Fxr (nr1h4) modulating compounds |
| AU2018243719B2 (en) | 2017-03-28 | 2021-01-21 | Gilead Sciences, Inc. | Therapeutic combinations for treating liver diseases |
| SG11202107434PA (en) | 2019-01-15 | 2021-08-30 | Gilead Sciences Inc | Fxr (nr1h4) modulating compounds |
| KR102725082B1 (ko) | 2019-02-19 | 2024-11-04 | 길리애드 사이언시즈, 인코포레이티드 | Fxr 효능제의 고체 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
| TW200911808A (en) * | 2007-07-23 | 2009-03-16 | Astrazeneca Ab | Novel compounds |
-
2009
- 2009-03-16 FR FR0901220A patent/FR2943059A1/fr active Pending
-
2010
- 2010-03-15 KR KR1020117024140A patent/KR20120013325A/ko not_active Withdrawn
- 2010-03-15 RU RU2011141760/04A patent/RU2011141760A/ru unknown
- 2010-03-15 SG SG2011066842A patent/SG174432A1/en unknown
- 2010-03-15 EP EP10715933A patent/EP2408778A1/fr not_active Withdrawn
- 2010-03-15 JP JP2012500293A patent/JP2012520346A/ja not_active Withdrawn
- 2010-03-15 AR ARP100100801A patent/AR075838A1/es unknown
- 2010-03-15 BR BRPI1009497-0A patent/BRPI1009497A2/pt not_active IP Right Cessation
- 2010-03-15 AU AU2010224721A patent/AU2010224721A1/en not_active Abandoned
- 2010-03-15 MX MX2011009746A patent/MX2011009746A/es not_active Application Discontinuation
- 2010-03-15 US US13/256,834 patent/US20120029027A1/en not_active Abandoned
- 2010-03-15 WO PCT/FR2010/050448 patent/WO2010106270A1/fr active Application Filing
- 2010-03-15 TW TW099107513A patent/TW201100431A/zh unknown
- 2010-03-15 CA CA2755528A patent/CA2755528A1/fr not_active Abandoned
- 2010-03-15 CN CN2010800121523A patent/CN102356084A/zh active Pending
- 2010-03-16 UY UY0001032496A patent/UY32496A/es not_active Application Discontinuation
-
2011
- 2011-09-12 IL IL215103A patent/IL215103A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201100431A (en) | 2011-01-01 |
| RU2011141760A (ru) | 2013-04-27 |
| CN102356084A (zh) | 2012-02-15 |
| AR075838A1 (es) | 2011-04-27 |
| US20120029027A1 (en) | 2012-02-02 |
| SG174432A1 (en) | 2011-10-28 |
| KR20120013325A (ko) | 2012-02-14 |
| IL215103A0 (en) | 2011-12-29 |
| UY32496A (es) | 2010-10-29 |
| WO2010106270A1 (fr) | 2010-09-23 |
| AU2010224721A1 (en) | 2011-10-06 |
| EP2408778A1 (fr) | 2012-01-25 |
| CA2755528A1 (fr) | 2010-09-23 |
| BRPI1009497A2 (pt) | 2018-03-13 |
| FR2943059A1 (fr) | 2010-09-17 |
| JP2012520346A (ja) | 2012-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY153393A (en) | Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors | |
| MX2009005449A (es) | Compuesto heteromonociclico y uso del mismo. | |
| MX2009002802A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparacion y su aplicacion en terapeutica. | |
| AU2006325931A8 (en) | Amine compound and use thereof for medical purposes | |
| MX2011009746A (es) | Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. | |
| MX2012001313A (es) | Compuesto espirociclicos que contienen nitrogeno y su uso medicinal. | |
| WO2009156861A8 (en) | Substituted pyrimidone derivatives | |
| MX344927B (es) | Composición farmacéutica que contiene derivado de quinolina. | |
| WO2009118473A3 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| MX2011009146A (es) | Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh. | |
| WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
| MX2008016558A (es) | Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas. | |
| TW201129564A (en) | Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof | |
| MX2010003576A (es) | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. | |
| WO2008006625A3 (en) | Derivatives of urea and related diamines, methods for their manufacture, and uses therefor | |
| MY165634A (en) | Pyrazole compounds having therapeutic effect on multiple myeloma | |
| TW200621694A (en) | Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds | |
| TW200708506A (en) | Derivatives of triazines, their preparation and their application in therapeutics | |
| TW200738681A (en) | Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics | |
| MY161067A (en) | Azabicycloalkane derivatives, preparation thereof and use thereof in therapy | |
| MX2010007348A (es) | Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion terapeutica. | |
| MX2011010929A (es) | Derivados de n-[7-aza-biciclo[2.2.1]hept-1-il)-aril-metil]-benzami da, su preparacion y su uso en terapeutica. | |
| TW200801016A (en) | Thienopyridine-2-carboxamide derivatives | |
| NZ593344A (en) | Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics | |
| MX2011009677A (es) | Derivados de n-[(2-aza-biciclo[2.1.1]hex-1-il)-aril-metil]-heterob enzamida, su preparacion y su aplicacion en terapeutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |